CHSY1 and colorectal carcinoma: The present study innovatively demonstrated that CHSY1 can promote CD8+ T cell depletion and lead to CRC liver metastasis through activation of the succinate metabolic pathway, providing new clues for immunotherapy of CRC liver metastasis.